-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Titan Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Titan Pharmaceuticals Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.07M, a 30.6% decline year-over-year.
- Titan Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$7.13M, a 16.5% increase year-over-year.
- Titan Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was -$7.28M, a 28.9% increase from 2022.
- Titan Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$10.2M, a 9.42% decline from 2021.
- Titan Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$9.35M, a 27.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)